Enviar rexistro por email: Increased Chemosensitivity via Targeting Testicular Nuclear Receptor 4 (TR4)-Oct4-Interleukin 1 Receptor Antagonist (IL1Ra) Axis in Prostate Cancer CD133(+) Stem/Progenitor Cells to Battle Prostate Cancer